Chryseobacterium indologenes, a possible emergent organism resistant to carbapenem antimicrobials after stem cell transplantation

A 64‐year‐old female was diagnosed with adult T‐cell leukemia/lymphoma. She then underwent an unrelated allogeneic bone marrow transplantation with a reduced‐intensity regimen. She achieved engraftment followed by HHV‐6 encephalopathy. This was complicated by Chryseobacterium indologenes pneumonia....

Descripción completa

Detalles Bibliográficos
Autores principales: Imataki, Osamu, Uemura, Makiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224769/
https://www.ncbi.nlm.nih.gov/pubmed/28096984
http://dx.doi.org/10.1002/ccr3.753
Descripción
Sumario:A 64‐year‐old female was diagnosed with adult T‐cell leukemia/lymphoma. She then underwent an unrelated allogeneic bone marrow transplantation with a reduced‐intensity regimen. She achieved engraftment followed by HHV‐6 encephalopathy. This was complicated by Chryseobacterium indologenes pneumonia. Chryseobacterium indologenes is now a possible emergent organism resistant to carbapenem after transplantation.

Ejemplares similares